Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global IVD (In Vitro Diagnostics) Products Market by Type (Immuno Diagnostics, Molecular Diagnostics, Tissue Diagnostics, Others), By Application (Hospital, Laboratories, Research & Academic, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global IVD (In Vitro Diagnostics) Products Market by Type (Immuno Diagnostics, Molecular Diagnostics, Tissue Diagnostics, Others), By Application (Hospital, Laboratories, Research & Academic, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 250080 4200 Medical Devices & Consumables 377 245 Pages 4.7 (48)
                                          

Market Overview:


The global IVD products market is expected to grow at a CAGR of 6.5% during the forecast period 2018-2030. The market growth can be attributed to the increasing incidence of chronic diseases, rising demand for personalized medicine, and technological advancements in the field of diagnostics. The global IVD products market is segmented on the basis of type into immunodiagnostics, molecular diagnostics, tissue diagnostics, and others. Immunodiagnostics accounted for the largest share in 2017 and is expected to maintain its dominance during the forecast period owing to increasing demand for point-of-care testing (POCT) devices. Molecular diagnostics is projected to grow at a highest CAGR during 2018-2030 due to its growing application in cancer diagnosis and prenatal screening. On the basis of application, hospitals accounted for majority share in 2017 followed by laboratories and research & academic institutions respectively.


Global IVD (In Vitro Diagnostics) Products Industry Outlook


Product Definition:


IVD products are used to detect and diagnose diseases or conditions. They can also be used to monitor the effectiveness of treatments. IVD products play an important role in healthcare, as they allow for early detection and treatment of diseases.


Immuno Diagnostics:


The global immuno diagnostics, it's usage and growth factor in IVD (In Vitro Diagnostics) Products market size was valued at USD 4.5 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The rising prevalence of chronic diseases such as cancer, diabetes, autoimmune disorders & other infectious diseases are anticipated to boost demand for immuno-diagnostics products thereby influencing industry growth over the forecast period.


Molecular Diagnostics:


Molecular diagnostics is a set of procedures used to identify and analyze genetic elements in an individual. It also helps in determining the cause of various diseases and disorders. These tests are performed by laboratories, physicians, or other healthcare professionals using various techniques such as PCR (polymerase chain reaction), DNA sequencing, etc. Molecular diagnostic tests are used for the diagnosis of cancer; infectious diseases; cardiovascular disease; diabetes mellitus; etc.


Application Insights:


The hospital application segment dominated the global market in 2017. The growth of this segment can be attributed to the increasing prevalence of chronic diseases and rising number of surgeries. A large number of players are focusing on enhancing their product portfolio for IVD kits that are used in hospitals for diagnosing various diseases efficiently. For instance, Roche offers full range diagnostic solutions that enable healthcare professionals to deliver precise diagnoses with greater efficiency and accuracy at a lower cost than ever before.


Rising demand for point-of-care testing across several applications such as laboratories, hospitals, clinics and others is expected to boost revenue generation over the forecast period. In addition, growing investments by governments & private institutions in developing advanced diagnostic technologies are anticipated to further fuel industry expansion over the coming years (8% CAGR).  Increasing R&D activities pertaining towards advance IVF techniques is also projecteded drive demand over next eight years (0% CAGR).


Regional Analysis:


North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and rising demand for point-of-care (PoC) diagnostic products. The U.S., which is at the forefront of this region, has been witnessing a significant increase in healthcare spending owing to an increasing number of chronic diseases that require regular monitoring and timely treatment.


Growth Factors:


  • Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. This has led to a surge in demand for diagnostic tests, which in turn is benefiting the IVD products market.
  • Technological advancements: The IVD products market is witnessing rapid technological advancements, with new and innovative products being launched regularly. This is helping to boost demand for these products, as they offer better accuracy and reliability than traditional methods.
  • Rising awareness about preventive healthcare: There has been a growing awareness among people about the importance of preventive healthcare measures in order to stay healthy and avoid serious illnesses later in life. This has led to an increase in demand for diagnostic tests, which are essential for early diagnosis and treatment of various health conditions.

Scope Of The Report

Report Attributes

Report Details

Report Title

IVD (In Vitro Diagnostics) Products Market Research Report

By Type

Immuno Diagnostics, Molecular Diagnostics, Tissue Diagnostics, Others

By Application

Hospital, Laboratories, Research & Academic, Others

By Companies

Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, Becton Dickinson, BioMérieuxSA, Immucor, Illumina, Luminex Corporation, CareDx, Hologic, GenDx, Biofortuna, QIAGEN NV, Bio-Rad Laboratories

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

245

Number of Tables & Figures

172

Customization Available

Yes, the report can be customized as per your need.


Global IVD (In Vitro Diagnostics) Products Market Report Segments:

The global IVD (In Vitro Diagnostics) Products market is segmented on the basis of:

Types

Immuno Diagnostics, Molecular Diagnostics, Tissue Diagnostics, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospital, Laboratories, Research & Academic, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Thermo Fisher Scientific
  2. Roche Diagnostics
  3. Abbott Laboratories
  4. Becton Dickinson
  5. BioMérieuxSA
  6. Immucor
  7. Illumina
  8. Luminex Corporation
  9. CareDx
  10. Hologic
  11. GenDx
  12. Biofortuna
  13. QIAGEN NV
  14. Bio-Rad Laboratories

Global IVD (In Vitro Diagnostics) Products Market Overview


Highlights of The IVD (In Vitro Diagnostics) Products Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Immuno Diagnostics
    2. Molecular Diagnostics
    3. Tissue Diagnostics
    4. Others
  1. By Application:

    1. Hospital
    2. Laboratories
    3. Research & Academic
    4. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the IVD (In Vitro Diagnostics) Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global IVD (In Vitro Diagnostics) Products Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


IVD products are diagnostic tests that are performed in vitro, meaning outside of the body. IVD tests can be used to diagnose a variety of medical conditions, including cancer and heart disease.

Some of the major companies in the ivd (in vitro diagnostics) products market are Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, Becton Dickinson, BioM©rieuxSA, Immucor, Illumina, Luminex Corporation, CareDx, Hologic, GenDx, Biofortuna, QIAGEN NV, Bio-Rad Laboratories.

The ivd (in vitro diagnostics) products market is expected to register a CAGR of 6.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 IVD (In Vitro Diagnostics) Products Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 IVD (In Vitro Diagnostics) Products Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 IVD (In Vitro Diagnostics) Products Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the IVD (In Vitro Diagnostics) Products Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global IVD (In Vitro Diagnostics) Products Market Size & Forecast, 2018-2028       4.5.1 IVD (In Vitro Diagnostics) Products Market Size and Y-o-Y Growth       4.5.2 IVD (In Vitro Diagnostics) Products Market Absolute $ Opportunity

Chapter 5 Global IVD (In Vitro Diagnostics) Products Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 IVD (In Vitro Diagnostics) Products Market Size Forecast by Type
      5.2.1 Immuno Diagnostics
      5.2.2 Molecular Diagnostics
      5.2.3 Tissue Diagnostics
      5.2.4 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global IVD (In Vitro Diagnostics) Products Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 IVD (In Vitro Diagnostics) Products Market Size Forecast by Applications
      6.2.1 Hospital
      6.2.2 Laboratories
      6.2.3 Research & Academic
      6.2.4 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global IVD (In Vitro Diagnostics) Products Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 IVD (In Vitro Diagnostics) Products Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America IVD (In Vitro Diagnostics) Products Analysis and Forecast
   9.1 Introduction
   9.2 North America IVD (In Vitro Diagnostics) Products Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America IVD (In Vitro Diagnostics) Products Market Size Forecast by Type
      9.6.1 Immuno Diagnostics
      9.6.2 Molecular Diagnostics
      9.6.3 Tissue Diagnostics
      9.6.4 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America IVD (In Vitro Diagnostics) Products Market Size Forecast by Applications
      9.10.1 Hospital
      9.10.2 Laboratories
      9.10.3 Research & Academic
      9.10.4 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe IVD (In Vitro Diagnostics) Products Analysis and Forecast
   10.1 Introduction
   10.2 Europe IVD (In Vitro Diagnostics) Products Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe IVD (In Vitro Diagnostics) Products Market Size Forecast by Type
      10.6.1 Immuno Diagnostics
      10.6.2 Molecular Diagnostics
      10.6.3 Tissue Diagnostics
      10.6.4 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe IVD (In Vitro Diagnostics) Products Market Size Forecast by Applications
      10.10.1 Hospital
      10.10.2 Laboratories
      10.10.3 Research & Academic
      10.10.4 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific IVD (In Vitro Diagnostics) Products Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific IVD (In Vitro Diagnostics) Products Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific IVD (In Vitro Diagnostics) Products Market Size Forecast by Type
      11.6.1 Immuno Diagnostics
      11.6.2 Molecular Diagnostics
      11.6.3 Tissue Diagnostics
      11.6.4 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific IVD (In Vitro Diagnostics) Products Market Size Forecast by Applications
      11.10.1 Hospital
      11.10.2 Laboratories
      11.10.3 Research & Academic
      11.10.4 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America IVD (In Vitro Diagnostics) Products Analysis and Forecast
   12.1 Introduction
   12.2 Latin America IVD (In Vitro Diagnostics) Products Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America IVD (In Vitro Diagnostics) Products Market Size Forecast by Type
      12.6.1 Immuno Diagnostics
      12.6.2 Molecular Diagnostics
      12.6.3 Tissue Diagnostics
      12.6.4 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America IVD (In Vitro Diagnostics) Products Market Size Forecast by Applications
      12.10.1 Hospital
      12.10.2 Laboratories
      12.10.3 Research & Academic
      12.10.4 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) IVD (In Vitro Diagnostics) Products Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) IVD (In Vitro Diagnostics) Products Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) IVD (In Vitro Diagnostics) Products Market Size Forecast by Type
      13.6.1 Immuno Diagnostics
      13.6.2 Molecular Diagnostics
      13.6.3 Tissue Diagnostics
      13.6.4 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) IVD (In Vitro Diagnostics) Products Market Size Forecast by Applications
      13.10.1 Hospital
      13.10.2 Laboratories
      13.10.3 Research & Academic
      13.10.4 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 IVD (In Vitro Diagnostics) Products Market: Competitive Dashboard
   14.2 Global IVD (In Vitro Diagnostics) Products Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Thermo Fisher Scientific
      14.3.2 Roche Diagnostics
      14.3.3 Abbott Laboratories
      14.3.4 Becton Dickinson
      14.3.5 BioMérieuxSA
      14.3.6 Immucor
      14.3.7 Illumina
      14.3.8 Luminex Corporation
      14.3.9 CareDx
      14.3.10 Hologic
      14.3.11 GenDx
      14.3.12 Biofortuna
      14.3.13 QIAGEN NV
      14.3.14 Bio-Rad Laboratories

Our Trusted Clients

Contact Us